img

Myeloproliferative Disorders Drugs/Treatment Market Size – By Disorder Type (Ph+ CML, Ph- MPN [Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis]), Drug Class (Tyrosine Kinase, JAK), Route of Administration, End-use & Forecast, 2024 – 2032


Published on: 2024-07-20 | No of Pages : 240 | Industry : Healthcare

Publisher : MIR | Format : PDF&Excel